Alice Guan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alice Guan has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Salma Shariff-Marco
Department of Epidemiology and Biostatistics, University of California , San Francisco, CA
10 shared publications - Scarlett Lin Gomez
Department of Epidemiology and Biostatistics University of California San Francisco San Francisco California USA
8 shared publications - Katherine Lin
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California
7 shared publications - Alison J. Canchola
Department of Epidemiology and Biostatistics, University of California, San Francisco (UCSF), San Francisco, California
5 shared publications - Dan Meltzer
California Environmental Health Tracking Program, Public Health Institute, Oakland, California, USA
5 shared publications - Iona Cheng
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, USA
5 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
Impact of Race and Geography on Medication-Assisted Treatment Prevalence for Opioid-Use Disorder
Was not provided for this article.
- 9 September 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
Open AccessImpact of Race and Geography on Medication-Assisted Treatment Prevalence for Opioid-Use Disorder
Was not provided for this article.
- Open Access
- 8 July 2026
- Published by Frontiers Media SA in Frontiers in Human Dynamics
- Vol. 8, 1847213
Active surveillance and trajectories of decision-making among patients with low-risk prostate cancer
Objectives: Prostate cancer is the most common cancer among men in the United States. This study examines factors associated with active surveillance (AS) uptake, timing of treatment decision making, and whether timing affects quality of life. Methods: We used data from a population-based observational study of 512 patients aged 40–79 diagnosed with low-risk prostate cancer from 2016 to 2022. Factors associated with AS receipt and treatment decision-making trajectories were assessed using robust Poisson regression models. Patient-reported satisfaction with treatment and PROMIS measures were analyzed using Poisson and linear regression. Results: AS uptake was 70.9% in the overall sample, higher among non-Hispanic (NH) White (76.6%) and NH Asian American/Pacific Islander (75.0%) patients than among NH Black (64.1%) and Hispanic (57.3%) patients. In adjusted models, higher education was associated with greater AS uptake (prevalence ratio (PR): 1.35; 95% CI: 1.02–1.78), and Hispanic patients were less likely to choose AS (PR: 0.80; 95% CI: 0.65–0.99). Older patients were more likely to delay disease management decisions (60–69 years: PR: 1.47; 95% CI: 1.09–1.98; 70 + years: PR: 1.67; 95% CI: 1.17–2.37), while partnered patients were less likely to delay (PR: 0.69; 95% CI: 0.54–0.88). Late deciders reported lower satisfaction with treatment decisions (PR: 0.92; 95% CI: 0.85–0.99) and higher anxiety scores at follow-up (coef: 1.86; 95% CI: 0.15–3.57). Conclusions: Hispanic patients, those who completed less education, and older patients face barriers to timely decisions about disease management. Partner involvement supports earlier decisions, while later decision was linked to lower satisfaction and higher anxiety.
- 8 July 2026
- Published by Frontiers Media SA in Frontiers in Human Dynamics
- Vol. 8, 1847213
Open AccessActive surveillance and trajectories of decision-making among patients with low-risk prostate cancer
Objectives: Prostate cancer is the most common cancer among men in the United States. This study examines factors associated with active surveillance (AS) uptake, timing of treatment decision making, and whether timing affects quality of life. Methods: We used data from a population-based observational study of 512 patients aged 40–79 diagnosed with low-risk prostate cancer from 2016 to 2022. Factors associated with AS receipt and treatment decision-making trajectories were assessed using robust Poisson regression models. Patient-reported satisfaction with treatment and PROMIS measures were analyzed using Poisson and linear regression. Results: AS uptake was 70.9% in the overall sample, higher among non-Hispanic (NH) White (76.6%) and NH Asian American/Pacific Islander (75.0%) patients than among NH Black (64.1%) and Hispanic (57.3%) patients. In adjusted models, higher education was associated with greater AS uptake (prevalence ratio (PR): 1.35; 95% CI: 1.02–1.78), and Hispanic patients were less likely to choose AS (PR: 0.80; 95% CI: 0.65–0.99). Older patients were more likely to delay disease management decisions (60–69 years: PR: 1.47; 95% CI: 1.09–1.98; 70 + years: PR: 1.67; 95% CI: 1.17–2.37), while partnered patients were less likely to delay (PR: 0.69; 95% CI: 0.54–0.88). Late deciders reported lower satisfaction with treatment decisions (PR: 0.92; 95% CI: 0.85–0.99) and higher anxiety scores at follow-up (coef: 1.86; 95% CI: 0.15–3.57). Conclusions: Hispanic patients, those who completed less education, and older patients face barriers to timely decisions about disease management. Partner involvement supports earlier decisions, while later decision was linked to lower satisfaction and higher anxiety.
- 2 June 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (7) , OF1-OF12
Ethnic Enclave Residence and Breast, Cervical, and Colorectal Cancer Incidence among Asian American Adults, 2006 to 2017
Background: Ethnic enclaves are culturally or ethnically distinct neighborhoods with high concentrations of individuals with shared ethnic origins, immigrants, and/or ethnic-specific businesses. We examined whether residence in Asian American enclaves was associated with the incidence of three screening-amenable cancers, using a composite enclave index across five US states. Methods: Using cancer registry data, we identified 74,485 breast, 4,134 cervical, and 35,736 colorectal cancer tumors diagnosed in California, Florida, New Jersey, New York, and Texas from January 1, 2006, to December 31, 2017, in Asian American adults. Age-adjusted incidence rates and incidence rate ratios (IRR) were calculated for 2006 to 2011 and 2012 to 2017 for census tract (CT)–level enclave and poverty measures, separately and jointly. Results: Breast and colorectal cancer incidence rates were lower among Asian American adults residing in the least culturally distinct neighborhoods compared with the most distinct [2012–2017: IRR 0.71; 95% confidence interval (CI), 0.65–0.76 in quintile 1 (Q1; low) compared with Q5 (high) for breast; IRR 0.62; 95% CI, 0.52–0.74 in Q1 vs. Q5 for colorectal cancer in males], whereas no association was found with enclave for cervical cancer. Higher cervical cancer rates were associated with high-poverty areas. For breast cancer, the highest incidence rates were observed in low-poverty enclaves, whereas for colorectal cancer, the highest rates were observed in high-poverty enclaves. Conclusions: Breast and colorectal cancer incidence rates were associated with residence in Asian American enclaves and CT poverty, though patterns differed by cancer site. Impact: Cancer prevention outreach may be beneficial within Asian American enclaves.
- 2 June 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (7) , OF1-OF12
Ethnic Enclave Residence and Breast, Cervical, and Colorectal Cancer Incidence among Asian American Adults, 2006 to 2017
Background: Ethnic enclaves are culturally or ethnically distinct neighborhoods with high concentrations of individuals with shared ethnic origins, immigrants, and/or ethnic-specific businesses. We examined whether residence in Asian American enclaves was associated with the incidence of three screening-amenable cancers, using a composite enclave index across five US states. Methods: Using cancer registry data, we identified 74,485 breast, 4,134 cervical, and 35,736 colorectal cancer tumors diagnosed in California, Florida, New Jersey, New York, and Texas from January 1, 2006, to December 31, 2017, in Asian American adults. Age-adjusted incidence rates and incidence rate ratios (IRR) were calculated for 2006 to 2011 and 2012 to 2017 for census tract (CT)–level enclave and poverty measures, separately and jointly. Results: Breast and colorectal cancer incidence rates were lower among Asian American adults residing in the least culturally distinct neighborhoods compared with the most distinct [2012–2017: IRR 0.71; 95% confidence interval (CI), 0.65–0.76 in quintile 1 (Q1; low) compared with Q5 (high) for breast; IRR 0.62; 95% CI, 0.52–0.74 in Q1 vs. Q5 for colorectal cancer in males], whereas no association was found with enclave for cervical cancer. Higher cervical cancer rates were associated with high-poverty areas. For breast cancer, the highest incidence rates were observed in low-poverty enclaves, whereas for colorectal cancer, the highest rates were observed in high-poverty enclaves. Conclusions: Breast and colorectal cancer incidence rates were associated with residence in Asian American enclaves and CT poverty, though patterns differed by cancer site. Impact: Cancer prevention outreach may be beneficial within Asian American enclaves.
- 1 July 2025
- Published by Oxford University Press (OUP) in JNCI Monographs
- Vol. 2025 (69) , 111-116
Perspectives on sexual orientation and gender identity data collection from healthcare system staff and leadership: case study in an academic hospital setting
Collecting sexual orientation and gender identity (SOGI) data in healthcare settings is essential for addressing the unique health needs and cancer burden of this population. We conducted a qualitative study to assess institutional leadership and staff perspectives on collecting SOGI data, aiming to improve these processes within our academic medical center. In key informant interviews with 17 staff and leaders, we asked about current SOGI data collection practices and facilitators/barriers for implementing systematic data collection. We sought to understand staff experiences with SOGI data collection, comfort and willingness to collect these data, and challenges in broad implementation of SOGI data collection. Findings indicate need for: training on SOGI data collection to increase staff confidence in engaging with patients; clear workflows for when, how, and by whom SOGI data should be collected; and implementation of flexible approaches to data collection, while balancing patient privacy.
- 1 July 2025
- Published by Oxford University Press (OUP) in JNCI Monographs
- Vol. 2025 (69) , 111-116
Perspectives on sexual orientation and gender identity data collection from healthcare system staff and leadership: case study in an academic hospital setting
Collecting sexual orientation and gender identity (SOGI) data in healthcare settings is essential for addressing the unique health needs and cancer burden of this population. We conducted a qualitative study to assess institutional leadership and staff perspectives on collecting SOGI data, aiming to improve these processes within our academic medical center. In key informant interviews with 17 staff and leaders, we asked about current SOGI data collection practices and facilitators/barriers for implementing systematic data collection. We sought to understand staff experiences with SOGI data collection, comfort and willingness to collect these data, and challenges in broad implementation of SOGI data collection. Findings indicate need for: training on SOGI data collection to increase staff confidence in engaging with patients; clear workflows for when, how, and by whom SOGI data should be collected; and implementation of flexible approaches to data collection, while balancing patient privacy.
- Open Access
- 5 March 2025
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 3 (3) , qxaf029
LGB (lesbian, gay, and bisexual) state policy protections and substance use disparities
LGB (lesbian, gay, and bisexual) individuals have higher rates of tobacco and alcohol use than the general population. While protective social policies have been found to reduce these disparities, their long-term impact remains largely unknown. In this study, we used data from waves 3 (2001–2002) and 4 (2008–2009) of the National Longitudinal Study of Adolescent to Adult Health to assess the impact of exposure to LGB state policy protections during emerging adulthood on substance use in young adulthood. Using multivariable Poisson models, we evaluated whether emerging adulthood was a critical period of exposure and quantified the relative reduction in substance use disparities between LGB and heterosexual individuals living in more protective states. Findings suggest that LGB individuals living in states with more policy protections during emerging adulthood had a significantly lower prevalence of tobacco use and binge drinking in young adulthood compared with those in less protective states. These findings were not observed among heterosexual individuals, indicating that policy effects were specific to LGB individuals. Furthermore, these protections appeared to reduce overall substance use disparities, especially among female participants. It is critical to continue evaluating policy protections to safeguard the health of the LGB community, especially considering the potential erosion of these vital protections.
- 5 March 2025
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 3 (3) , qxaf029
Open AccessLGB (lesbian, gay, and bisexual) state policy protections and substance use disparities
LGB (lesbian, gay, and bisexual) individuals have higher rates of tobacco and alcohol use than the general population. While protective social policies have been found to reduce these disparities, their long-term impact remains largely unknown. In this study, we used data from waves 3 (2001–2002) and 4 (2008–2009) of the National Longitudinal Study of Adolescent to Adult Health to assess the impact of exposure to LGB state policy protections during emerging adulthood on substance use in young adulthood. Using multivariable Poisson models, we evaluated whether emerging adulthood was a critical period of exposure and quantified the relative reduction in substance use disparities between LGB and heterosexual individuals living in more protective states. Findings suggest that LGB individuals living in states with more policy protections during emerging adulthood had a significantly lower prevalence of tobacco use and binge drinking in young adulthood compared with those in less protective states. These findings were not observed among heterosexual individuals, indicating that policy effects were specific to LGB individuals. Furthermore, these protections appeared to reduce overall substance use disparities, especially among female participants. It is critical to continue evaluating policy protections to safeguard the health of the LGB community, especially considering the potential erosion of these vital protections.
- Open Access
- 9 January 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021
Supplemental Table 1. Population counts per pandemic time period and absolute change in percentage of late-stage cancer diagnoses for Post-Shutdown #2 and Post-Vaccine Rollout
- 9 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021
Supplemental Table 1. Population counts per pandemic time period and absolute change in percentage of late-stage cancer diagnoses for Post-Shutdown #2 and Post-Vaccine Rollout
- Open Access
- 9 January 2025
- Published by American Association for Cancer Research (AACR)
Data from Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021
Background:The COVID-19 pandemic and associated shutdowns disrupted healthcare access and resulted in decreased cancer screenings. Cancer diagnosis delays have concerning downstream effects on late-stage cancer, especially for marginalized populations.Methods:The study population included 349,458 adults in the California Cancer Registry diagnosed with cancer between January 2019 and December 2021, during which California experienced two stay-at-home orders. We examined the percentage of late-stage (III–IV) cancer diagnoses across five periods: Pre-pandemic (January 2019–February 2020), Shutdown #1 (March–June 2020), Post-shutdown #1 (July–November 2020), Post-shutdown #2 (December 2020–March 2021), and Post-vaccine rollout (April–December 2021). To examine the association between time period and late-stage diagnoses, we conducted a multivariable log-binomial regression model adjusted for sociodemographic and neighborhood factors.Results:The percentage of late-stage cancer diagnoses increased during Shutdown #1 (+5.2%) and returned to baseline Post-vaccine rollout. Groups with notably higher increases in the percentage of late-stage cancer (vs. overall population) during Shutdown #1 include Pacific Islander (+13.7%), Thai (+11.2%), Chinese (+8.1%), Native Hawaiian (+7.4%), Filipino (+6.6%), and uninsured (+7.4%). Uninsured [vs. private insurance; prevalence ratio (PR), 1.41], low neighborhood socioeconomic status (nSES; vs. high; PR, 1.19), and racial and ethnic minoritized groups (vs. non-Hispanic White; PR, 1.04–1.19) had higher likelihood for late-stage cancer diagnosis.Conclusions:The pandemic exacerbated late-stage cancer disparities for racial and ethnic minoritized groups, underinsured, and low nSES communities in California (2020–2021).Impact:Interventions to improve cancer screening must be focused on racial and ethnic minoritized, underinsured, and low nSES communities, as they are likely to be more vulnerable to healthcare disruptions like the pandemic.
- 9 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021
Background:The COVID-19 pandemic and associated shutdowns disrupted healthcare access and resulted in decreased cancer screenings. Cancer diagnosis delays have concerning downstream effects on late-stage cancer, especially for marginalized populations.Methods:The study population included 349,458 adults in the California Cancer Registry diagnosed with cancer between January 2019 and December 2021, during which California experienced two stay-at-home orders. We examined the percentage of late-stage (III–IV) cancer diagnoses across five periods: Pre-pandemic (January 2019–February 2020), Shutdown #1 (March–June 2020), Post-shutdown #1 (July–November 2020), Post-shutdown #2 (December 2020–March 2021), and Post-vaccine rollout (April–December 2021). To examine the association between time period and late-stage diagnoses, we conducted a multivariable log-binomial regression model adjusted for sociodemographic and neighborhood factors.Results:The percentage of late-stage cancer diagnoses increased during Shutdown #1 (+5.2%) and returned to baseline Post-vaccine rollout. Groups with notably higher increases in the percentage of late-stage cancer (vs. overall population) during Shutdown #1 include Pacific Islander (+13.7%), Thai (+11.2%), Chinese (+8.1%), Native Hawaiian (+7.4%), Filipino (+6.6%), and uninsured (+7.4%). Uninsured [vs. private insurance; prevalence ratio (PR), 1.41], low neighborhood socioeconomic status (nSES; vs. high; PR, 1.19), and racial and ethnic minoritized groups (vs. non-Hispanic White; PR, 1.04–1.19) had higher likelihood for late-stage cancer diagnosis.Conclusions:The pandemic exacerbated late-stage cancer disparities for racial and ethnic minoritized groups, underinsured, and low nSES communities in California (2020–2021).Impact:Interventions to improve cancer screening must be focused on racial and ethnic minoritized, underinsured, and low nSES communities, as they are likely to be more vulnerable to healthcare disruptions like the pandemic.
- Open Access
- 9 January 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021
Supplemental Figure 1. Age distributions from 2019 vs. 2021 from American Community Survey (ACS) 2019-2021
- 9 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021
Supplemental Figure 1. Age distributions from 2019 vs. 2021 from American Community Survey (ACS) 2019-2021
- 31 October 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 34 (1) , 139-150
Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021
Background: The COVID-19 pandemic and associated shutdowns disrupted healthcare access and resulted in decreased cancer screenings. Cancer diagnosis delays have concerning downstream effects on late-stage cancer, especially for marginalized populations. Methods: The study population included 349,458 adults in the California Cancer Registry diagnosed with cancer between January 2019 and December 2021, during which California experienced two stay-at-home orders. We examined the percentage of late-stage (III–IV) cancer diagnoses across five periods: Pre-pandemic (January 2019–February 2020), Shutdown #1 (March–June 2020), Post-shutdown #1 (July–November 2020), Post-shutdown #2 (December 2020–March 2021), and Post-vaccine rollout (April–December 2021). To examine the association between time period and late-stage diagnoses, we conducted a multivariable log-binomial regression model adjusted for sociodemographic and neighborhood factors. Results: The percentage of late-stage cancer diagnoses increased during Shutdown #1 (+5.2%) and returned to baseline Post-vaccine rollout. Groups with notably higher increases in the percentage of late-stage cancer (vs. overall population) during Shutdown #1 include Pacific Islander (+13.7%), Thai (+11.2%), Chinese (+8.1%), Native Hawaiian (+7.4%), Filipino (+6.6%), and uninsured (+7.4%). Uninsured [vs. private insurance; prevalence ratio (PR), 1.41], low neighborhood socioeconomic status (nSES; vs. high; PR, 1.19), and racial and ethnic minoritized groups (vs. non-Hispanic White; PR, 1.04–1.19) had higher likelihood for late-stage cancer diagnosis. Conclusions: The pandemic exacerbated late-stage cancer disparities for racial and ethnic minoritized groups, underinsured, and low nSES communities in California (2020–2021). Impact: Interventions to improve cancer screening must be focused on racial and ethnic minoritized, underinsured, and low nSES communities, as they are likely to be more vulnerable to healthcare disruptions like the pandemic.
- 31 October 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 34 (1) , 139-150
Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021
Background: The COVID-19 pandemic and associated shutdowns disrupted healthcare access and resulted in decreased cancer screenings. Cancer diagnosis delays have concerning downstream effects on late-stage cancer, especially for marginalized populations. Methods: The study population included 349,458 adults in the California Cancer Registry diagnosed with cancer between January 2019 and December 2021, during which California experienced two stay-at-home orders. We examined the percentage of late-stage (III–IV) cancer diagnoses across five periods: Pre-pandemic (January 2019–February 2020), Shutdown #1 (March–June 2020), Post-shutdown #1 (July–November 2020), Post-shutdown #2 (December 2020–March 2021), and Post-vaccine rollout (April–December 2021). To examine the association between time period and late-stage diagnoses, we conducted a multivariable log-binomial regression model adjusted for sociodemographic and neighborhood factors. Results: The percentage of late-stage cancer diagnoses increased during Shutdown #1 (+5.2%) and returned to baseline Post-vaccine rollout. Groups with notably higher increases in the percentage of late-stage cancer (vs. overall population) during Shutdown #1 include Pacific Islander (+13.7%), Thai (+11.2%), Chinese (+8.1%), Native Hawaiian (+7.4%), Filipino (+6.6%), and uninsured (+7.4%). Uninsured [vs. private insurance; prevalence ratio (PR), 1.41], low neighborhood socioeconomic status (nSES; vs. high; PR, 1.19), and racial and ethnic minoritized groups (vs. non-Hispanic White; PR, 1.04–1.19) had higher likelihood for late-stage cancer diagnosis. Conclusions: The pandemic exacerbated late-stage cancer disparities for racial and ethnic minoritized groups, underinsured, and low nSES communities in California (2020–2021). Impact: Interventions to improve cancer screening must be focused on racial and ethnic minoritized, underinsured, and low nSES communities, as they are likely to be more vulnerable to healthcare disruptions like the pandemic.
- 16 September 2024
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 40 (4) , 739-748
Latino Enclaves and Healthcare Accessibility: An Ecologic Study Across Five States
Hispanic or Latino populations (hereafter, "Latinos") are a rapidly expanding U.S. demographic and have documented inequities in preventable diseases and conditions. Many Latinos reside in ethnic enclaves, and understanding the context and healthcare accessibility within these places is critical. This study described the neighborhood social and built environment attributes of Latino enclaves and evaluated associations between enclaves and geographic healthcare accessibility. Cross-sectional ecologic analysis. Our unit of analysis was all neighborhoods (n ~ 20,000 census tracts) in California, Florida, New Jersey, New York, and Texas in years 2000 and 2010. The primary exposure of interest, "Latino enclaves," was defined using neighborhood-level data on the percentage of Latino residents, foreign-born Latinos, Spanish speakers with limited English proficiency, and linguistically isolated Spanish-speaking households. The primary outcome was a neighborhood-level measure of geographic healthcare accessibility of primary care physicians, which accounted for both the supply of physicians and population demand for healthcare (i.e., population size within driving distance). Approximately 30% of neighborhoods were classified as Latino enclaves, 87% of which were enclaves in both 2000 and 2010. Compared with non-enclaves, Latino enclaves had more markers of structural disadvantage including having higher proportions of poverty, uninsured individuals, crowded housing, and higher crime scores. Results from multivariable models suggest that more culturally distinct neighborhoods (i.e., higher enclave score) had lower healthcare accessibility, though when stratified, this association persisted only in high (≥ 20%) poverty neighborhoods. This study highlights several neighborhood structural disadvantages within Latino enclaves, including higher poverty, uninsured individuals, and crime compared to non-enclave neighborhoods. Moreover, our findings point to the need for interventions aimed at improving healthcare accessibility particularly within socioeconomically disadvantaged Latino enclaves. Addressing these inequities demands multifaceted approaches that consider both social and structural factors to ensure equitable healthcare access for Latino populations.
- 16 September 2024
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 40 (4) , 739-748
Latino Enclaves and Healthcare Accessibility: An Ecologic Study Across Five States
Hispanic or Latino populations (hereafter, "Latinos") are a rapidly expanding U.S. demographic and have documented inequities in preventable diseases and conditions. Many Latinos reside in ethnic enclaves, and understanding the context and healthcare accessibility within these places is critical. This study described the neighborhood social and built environment attributes of Latino enclaves and evaluated associations between enclaves and geographic healthcare accessibility. Cross-sectional ecologic analysis. Our unit of analysis was all neighborhoods (n ~ 20,000 census tracts) in California, Florida, New Jersey, New York, and Texas in years 2000 and 2010. The primary exposure of interest, "Latino enclaves," was defined using neighborhood-level data on the percentage of Latino residents, foreign-born Latinos, Spanish speakers with limited English proficiency, and linguistically isolated Spanish-speaking households. The primary outcome was a neighborhood-level measure of geographic healthcare accessibility of primary care physicians, which accounted for both the supply of physicians and population demand for healthcare (i.e., population size within driving distance). Approximately 30% of neighborhoods were classified as Latino enclaves, 87% of which were enclaves in both 2000 and 2010. Compared with non-enclaves, Latino enclaves had more markers of structural disadvantage including having higher proportions of poverty, uninsured individuals, crowded housing, and higher crime scores. Results from multivariable models suggest that more culturally distinct neighborhoods (i.e., higher enclave score) had lower healthcare accessibility, though when stratified, this association persisted only in high (≥ 20%) poverty neighborhoods. This study highlights several neighborhood structural disadvantages within Latino enclaves, including higher poverty, uninsured individuals, and crime compared to non-enclave neighborhoods. Moreover, our findings point to the need for interventions aimed at improving healthcare accessibility particularly within socioeconomically disadvantaged Latino enclaves. Addressing these inequities demands multifaceted approaches that consider both social and structural factors to ensure equitable healthcare access for Latino populations.